Abstract
Radiation injury to normal tissues has been recognized for many decades, and is dependent upon a multitude of factors, including radiation dose and fractionation and volume of tissue or organ exposed to radiation. Since the 1980s, technologic innovations in imaging, radiation planning and radiation delivery have allowed for more accurate quantification of dose delivery to tissues, which in turn has resulted in a burgeoning research effort to understand and quantify risks to normal tissues after radiation. This chapter will broadly discuss factors that potentially influence the risk of radiation-normal tissue injury, provide a framework for understanding the differences and similarities between organs in their response to radiation, and describe additional considerations that might be more relevant in the future. It also reviews the major efforts in past 2 decades, namely the 1991 Emami, Lyman et al. review and the recent 2010 QUANTEC reviews, which compiled published data, summarized this data, and provided recommended organ dose/volume constraints.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahn SJ, Kahn D, Zhou S et al (2005) Dosimetric and clinical predictors for radiation-induced esophageal injury. Int J Radiat Oncol Biol Phys 61:335–347
Benedict SH, Yenice KM, Followill D et al (2010) Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys 37:4078–4101
Boersma LJ, Damen EM, de Boer RW et al (1993) A new method to determine dose-effect relations for local lung-function changes using correlated SPECT and CT data. Radiother Oncol 29:110–116
Burman C, Kutcher GJ, Emami B et al (1991) Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 21:123–135
Chapet O, Kong FM, Lee JS et al (2005) Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer. Radiother Oncol J Eur Soc Ther Radiol Oncol 77:176–181
Emami B, Lyman J, Brown A et al (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21:109–122
Fan M, Marks LB, Hollis D et al (2001a) Can we predict radiation-induced changes in pulmonary function based on the sum of predicted regional dysfunction? J Clin Oncol 19:543–550
Fan M, Marks LB, Lind P et al (2001b) Relating radiation-induced regional lung injury to changes in pulmonary function tests. Int J Radiat Oncol Biol Phys 51:311–317
Flickinger JC, Kondziolka D, Lunsford LD et al (2000) Development of a model to predict permanent symptomatic postradiosurgery injury for arteriovenous malformation patients. Arteriovenous malformation radiosurgery study group. Int J Radiat Oncol Biol Phys 46:1143–1148
Glatstein E (2008) Hypofractionation, long-term effects, and the alpha/beta ratio. Int J Radiat Oncol Biol Phys 72:11–12
Glatstein E (2011) The omega on alpha and beta. Int J Radiat Oncol Biol Phys 81:319–320
Hall EJ, Giaccia AJ (2012) Radiobiology for the radiobiologist, 7th edn. Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia
Hendry JH, Thames HD (1986) The tissue-rescuing unit. Br J Radiol 59:628–630
Jin JY, Kong FM, Chetty IJ et al (2010) Impact of fraction size on lung radiation toxicity: hypofractionation may be beneficial in dose escalation of radiotherapy for lung cancers. Int J Radiat Oncol Biol Phys 76:782–788
Kutcher GJ, Burman C, Brewster L et al (1991) Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. Int J Radiat Oncol Biol Phys 21:137–146
Lyman JT (1985) Complication probability as assessed from dose-volume histograms. Radiat Res. (Supplement) 8:S13–S19
Lyman JT, Wolbrast AB (1987) Optimization of radiation therapy III: a method of assessing complication probabilities from dose-volume histograms. Int J Radiat Oncol Biol Phys 13:103
Ma J, Zhang J, Zhou S et al (2009) Association between RT-induced changes in lung tissue density and global lung function. Int J Radiat Oncol Biol Phys 74:781–789
Ma J, Zhang J, Zhou S et al (2010) Regional lung density changes after radiation therapy for tumors in and around thorax. Int J Radiat Oncol Biol Phys 76:116–122
Mah K, Van Dyk J (1988) Quantitative measurement of changes in human lung density following irradiation. Radiother Oncol 11:169–179
Marks LB, Carroll PR, Dugan TC, Anscher MS (1995) The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys 31:1257–1280
Marks LB (1996) The impact of organ structure on radiation response. Int J Radiat Oncol Biol Phys 34:1165–1171
Marks LB, Munley MT, Spencer DP et al (1997) Quantification of radiation-induced regional lung injury with perfusion imaging. Int J Radiat Oncol Biol Phys 38:399–409
Marks LB, Ten Haken RK, Martel MK (2010a) Guest editor’s introduction to QUANTEC: a users guide. Int J Radiat Oncol Biol Phys 76:S1–S2
Marks LB, Yorke ED, Jackson A et al (2010b) Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 76:S10–S19
Marks LB, Bentzen SM, Deasy JO et al (2010c) Radiation dose volume effects in the lung. Int J Radiat Oncol Biol Phys 76:S70–S76
Mendelsohn ML (1969) The biology of dose-limiting tissuses. In: Time and dose relationship in radiation biology as applied to radiotherapy, Brookhaven National Laboratory [BNL] Report 5023 (C-57), Brookhaven National Laboratory, Upton, p 54
Michalowski A, Wheldon TE, Kirk J (1984) Can cell survival parameters be deduced from non clonogenic assays of radiation damage to normal tissues? Br J Cancer Suppl 6:257–261
Milano MT, Constine LS, Okunieff P (2007) Normal tissue tolerance dose metrics for radiation therapy of major organs. Semin Radiat Oncol 17:131–140
Milano MT, Constine LS, Okunieff P (2008) Normal tissue toxicity after small field hypofractionated stereotactic body radiation. Radiat Oncol 3:36
Milano MT, Marks LB, Constine LS (2012) Survivorship and late effects. In: Gunderson LL, Tepper JE (eds) Clinical radiation oncology, 3rd edn. Churchill Livingstone, Philadelphia, PA
Rubin P (1978) Clinical oncology: a multidisciplinary approach for physicians and students, 5th edn. American Cancer Society, Inc
Rubin P, Casarett GW (1968) Clinical radiation pathology. W. B. Saunders, Philadelphia
Rubin P, Casarett GW (1972) A direction for clinical radiation oncology. In: Vaeth JM (ed) Frontiers of radiation therapy and oncology VI. University Park Press, Baltimore, pp 1–16
Seppenwoolde Y, De Jaeger K, Boersma LJ et al (2004) Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 60:748–758
Ten Haken RK, Lawrence TS, Dawson LA () Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma: in regards to Xu et al. (Int J Radiat Oncol Biol Phys 2006;65:189–195). Int J Radiat Oncol Biol Phys 66:1272; author reply 1272–1273
Ten Haken RK, Martel MK, Kessler ML et al (1993) Use of Veff and iso-NTCP in the implementation of dose escalation protocols. Int J Radiat Oncol Biol Phys 27:689–695
Vanderstraeten B, Reynaert N, Paelinck L et al (2006) Accuracy of patient dose calculation for lung IMRT: a comparison of Monte Carlo, convolution/superposition, and pencil beam computations. Med Phys 33:3149–3158
Withers HR, Taylor JM (1993) Critical volume model. Int J Radiat Oncol Biol Phys 25:151–152
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Milano, M.T., Rubin, P., Marks, L.B. (2014). Understanding and Predicting Radiation-Associated Normal Tissue Injury: A Global and Historical Perspective. In: Rubin, P., Constine, L., Marks, L. (eds) ALERT - Adverse Late Effects of Cancer Treatment. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-72314-1_8
Download citation
DOI: https://doi.org/10.1007/978-3-540-72314-1_8
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-72313-4
Online ISBN: 978-3-540-72314-1
eBook Packages: MedicineMedicine (R0)